November 17, 2010 -- Sihuan Pharma has struck a deal to distribute alprostadil injection, a vasodilator, for Benxi Leilong Pharmaceutical Co. Sihuan will have exclusive rights for 30 years to distribute the drug to its network of almost 10,000 hospitals in China. According to Sihuan, alprostadil injection is one of the best-selling cardio-cerebral vascular drugs in China. The drug is a natural fit for Sihuan, which already makes and distributes a portfolio of 14 cardio-cerebral vascular drugs. More details....
